Abercrombie & Fitch (ANF) 10-Q 6 Dec 22 2022 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Oct. 29, 2022	Dec. 02, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 29, 2022
Document Transition Report	false
Entity File Number	001-12107
Entity Registrant Name	Abercrombie & Fitch Co.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	31-1469076
Entity Address, Address Line One	6301 Fitch Path,
Entity Address, City or Town	New Albany,
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	43054
City Area Code	(614)
Local Phone Number	283-6500
Title of 12(b) Security	Class A Common Stock, $0.01 Par Value
Trading Symbol	ANF
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		49,001,742
Entity Central Index Key	0001018840
Current Fiscal Year End Date	--01-28
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended			9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021		Oct. 29, 2022	Oct. 30, 2021
Document Period End Date				Oct. 29, 2022
Net sales	$ 880,084	$ 905,160		$ 2,497,937	$ 2,551,415
Cost of sales, exclusive of depreciation and amortization	359,268	328,916		1,061,684	916,552
Gross profit	520,816	576,244		1,436,253	1,634,863
Stores and distribution expense	367,333	351,815		1,045,667	993,170
Marketing, general and administrative expense	133,201	146,269		379,518	391,129
Other operating income, net	(1,005)	(1,320)		(3,894)	(4,586)
Operating income	17,543	72,731		5,626	244,951
Interest expense, net	7,295	7,270		21,519	27,151
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total	10,248	65,461		(15,893)	217,800
Income tax expense	10,966	16,383		14,413	15,560
Net (loss) income	(718)	49,078		(30,306)	202,240
Less: Net income attributable to noncontrolling interests	1,496	1,845		5,211	4,739
Net (loss) income attributable to A&F	$ (2,214)	$ 47,233		$ (35,517)	$ 197,501
Net (loss) income per share attributable to A&F
Basic	$ (0.04)	$ 0.80		$ (0.70)	$ 3.24
Diluted	$ (0.04)	$ 0.77		$ (0.70)	$ 3.10
Weighted-average shares outstanding
Basic	49,486	58,796		50,673	60,879
Diluted	49,486	61,465		50,673	63,770
Other comprehensive (loss) income
Foreign currency translation adjustments, net of tax	$ (11,021)	$ (5,629)		$ (26,338)	$ (8,889)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	(1,206)	4,416		(1,223)	9,718
Other comprehensive (loss) income	(12,227)	(1,213)	[1]	(27,561)	829
Comprehensive (loss) income	(12,945)	47,865		(57,867)	203,069
Less: Comprehensive income attributable to noncontrolling interests	1,496	1,845		5,211	4,739
Comprehensive (loss) income attributable to A&F	(14,441)	46,020		(63,078)	198,330
Asset Impairment Charges	$ 3,744	$ 6,749		$ 9,336	$ 10,199
[1]Amount represents loss reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income.

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Oct. 29, 2022	Jan. 29, 2022
Current assets:
Cash and equivalents	$ 257,332	$ 823,139
Receivables	108,468	69,102
Inventories	741,963	525,864
Other current assets	112,602	89,654
Total current assets	1,220,365	1,507,759
Property and equipment, net	542,138	508,336
Operating lease right-of-use assets	713,166	698,231
Other assets	218,325	225,165
Total assets	2,693,994	2,939,491
Current liabilities:
Accounts payable	322,128	374,829
Accrued expenses	378,366	395,815
Short-term portion of operating lease liabilities	211,304	222,823
Income taxes payable	23,694	21,773
Total current liabilities	935,492	1,015,240
Long-term liabilities:
Long-term portion of operating lease liabilities	708,512	697,264
Long-term portion of borrowings, net	296,532	303,574
Other liabilities	97,393	86,089
Total long-term liabilities	1,102,437	1,086,927
Stockholders’ equity
Class A Common Stock: $0.01 par value: 150,000 shares authorized and 103,300 shares issued for all periods presented	1,033	1,033
Paid-in capital	411,041	413,190
Retained earnings	2,330,730	2,386,156
Accumulated other comprehensive loss, net of tax (“AOCL”)	(142,267)	(114,706)
Treasury stock, at average cost: 54,300 and 50,315 shares as of October 29, 2022 and January 29, 2022, respectively	(1,954,306)	(1,859,583)
Total Abercrombie & Fitch Co. stockholders’ equity	646,231	826,090
Noncontrolling interests	9,834	11,234
Total stockholders’ equity	656,065	837,324
Total liabilities and stockholders’ equity	$ 2,693,994	$ 2,939,491

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - Class A Common Stock - $ / shares shares in Thousands	Oct. 29, 2022	Jan. 29, 2022
Stockholders’ equity
Class A Common Stock, par value	$ 0.01	$ 0.01
Class A Common Stock, shares authorized	150,000	150,000
Class A Common Stock, shares issued	103,300	103,300

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (Unaudited) $ in Thousands	9 Months Ended
	Oct. 29, 2022 USD ($)	Oct. 30, 2021 USD ($)
Document Period End Date	Oct. 29, 2022
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ (14,871)	$ (8,560)
Asset impairment	9,336	10,199
Operating activities
Net (loss) income	(30,306)	202,240
Adjustments to reconcile net (loss) income to net cash (used for) provided by operating activities:
Depreciation and amortization	98,393	107,787
Asset impairment	9,336	10,199
(Gain) loss on disposal	(198)	3,500
Benefit for deferred income taxes	(9,585)	(32,931)
Share-based compensation	23,426	22,269
(Gain) loss on extinguishment of debt	(52)	5,347
Changes in assets and liabilities:
Inventories	(221,414)	(140,393)
Accounts payable and accrued expenses	(87,463)	81,793
Operating lease right-of-use assets and liabilities	(8,364)	(105,046)
Income taxes	281	15,061
Other assets	(91,432)	(34,884)
Other liabilities	16,184	(3,655)
Net cash (used for) provided by operating activities	(301,194)	131,287
Investing activities
Purchases of property and equipment	(120,282)	(62,223)
Proceeds from Sale of Property, Plant, and Equipment	11,891	0
Withdrawal from Rabbi Trust Assets	12,000	0
Net cash used for investing activities	(96,391)	(62,223)
Financing activities
Repayments of Notes Payable	(7,862)	(46,969)
Payments of Debt Issuance Costs	(181)	(2,016)
Purchase of treasury stock	(125,775)	(235,249)
Other financing activities	(21,088)	(20,124)
Net cash used for financing activities	(154,906)	(304,358)
Net decrease in cash and equivalents, and restricted cash and equivalents	(567,362)	(243,854)
Cash and equivalents, and restricted cash, beginning of period	834,368	1,124,157
Cash and equivalents, and restricted cash and equivalents, end of period	267,006	880,303
Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]
Purchases of property and equipment not yet paid at end of period	64,477	31,561
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	(196,003)	(26,473)
Cash paid for interest	13,574	14,950
Cash paid for income taxes	26,213	39,081
Cash received from income tax refunds	249	1,240
Cash paid for operating lease liabilities	210,394	$ 312,854
Not Designated as Hedging Instruments
Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value	$ 0

Consolidated Statements of Stoc

Consolidated Statements of Stockholders Equity Statement - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Noncontrolling Interest [Member]	Retained Earnings [Member]	AOCI Including Portion Attributable to Noncontrolling Interest [Member]	Treasury Stock [Member]
Shares, Outstanding		62,399					40,901
Total Abercrombie & Fitch Co. stockholders’ equity		$ 1,033	$ 401,283		$ 2,149,470	$ (102,307)	$ (1,512,851)
Noncontrolling interests				$ 12,684
Total stockholders' equity	$ 949,312
Income (Loss) Attributable to Noncontrolling Interest, before Tax				4,739
Net Income (Loss) Attributable to Parent	197,501				197,501
Net (loss) income	202,240
Treasury Stock, Shares, Acquired		6,143					6,143
Treasury Stock, Value, Acquired, Cost Method	(235,249)						$ (235,249)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		781					(781)
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	(13,044)		(17,247)		(26,171)		$ 30,374
Share-based compensation expense	(22,269)		(22,269)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	9,718
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	(8,889)
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders	(8,028)			(8,028)
Shares, Outstanding		59,691					43,609
Total Abercrombie & Fitch Co. stockholders’ equity		$ 1,033	399,891		2,275,009	(100,265)	$ (1,619,102)
Noncontrolling interests				10,367
Total stockholders' equity	966,933
Income (Loss) Attributable to Noncontrolling Interest, before Tax				1,845
Net Income (Loss) Attributable to Parent	47,233				47,233
Net (loss) income	49,078
Treasury Stock, Shares, Acquired		2,692					2,692
Treasury Stock, Value, Acquired, Cost Method	(100,000)						$ (100,000)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		38					(38)
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	(984)		(918)		(1,442)		$ 1,376
Share-based compensation expense	(7,332)		(7,332)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	4,416
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	(5,629)
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders	(2,817)			(2,817)
Shares, Outstanding		57,037					46,263
Total Abercrombie & Fitch Co. stockholders’ equity		$ 1,033	406,305		2,320,800	(101,478)	$ (1,717,726)
Noncontrolling interests				9,395
Total stockholders' equity	918,329
Shares, Outstanding		52,985					50,315
Total Abercrombie & Fitch Co. stockholders’ equity	826,090	$ 1,033	413,190		2,386,156	(114,706)	$ (1,859,583)
Noncontrolling interests	11,234			11,234
Total stockholders' equity	837,324
Income (Loss) Attributable to Noncontrolling Interest, before Tax				5,211
Net Income (Loss) Attributable to Parent	(35,517)				(35,517)
Net (loss) income	(30,306)
Treasury Stock, Shares, Acquired		4,770					4,770
Treasury Stock, Value, Acquired, Cost Method	(125,775)						$ (125,775)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		785					(785)
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	(14,432)		(25,575)		(19,909)		$ 31,052
Share-based compensation expense	(23,426)		(23,426)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	(1,223)
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	(26,338)
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders	(6,611)			(6,611)
Shares, Outstanding		49,471					53,829
Total Abercrombie & Fitch Co. stockholders’ equity		$ 1,033	405,127		2,333,867	(130,040)	$ (1,948,199)
Noncontrolling interests				11,139
Total stockholders' equity	672,927
Income (Loss) Attributable to Noncontrolling Interest, before Tax				1,496
Net Income (Loss) Attributable to Parent	(2,214)				(2,214)
Net (loss) income	(718)
Treasury Stock, Shares, Acquired		510					510
Treasury Stock, Value, Acquired, Cost Method	(8,000)						$ (8,000)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		39					(39)
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	(426)		(1,396)		(923)		$ 1,893
Share-based compensation expense	(7,310)		(7,310)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	(1,206)
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	(11,021)
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders	(2,801)			(2,801)
Shares, Outstanding		49,000					54,300
Total Abercrombie & Fitch Co. stockholders’ equity	646,231	$ 1,033	$ 411,041		$ 2,330,730	$ (142,267)	$ (1,954,306)
Noncontrolling interests	9,834			$ 9,834
Total stockholders' equity	$ 656,065

Nature of Business (Notes)

Nature of Business (Notes)	9 Months Ended
	Oct. 29, 2022
Nature of Business [Abstract]
Nature of Business	NATURE OF BUSINESSAbercrombie & Fitch Co. (“A&F”), a company incorporated in Delaware in 1996, through its subsidiaries (collectively, A&F and its subsidiaries are referred to as “Abercrombie & Fitch” or the “Company”), is a global, digitally-led omnichannel retailer. The Company offers a broad assortment of apparel, personal care products and accessories for men, women and kids, which are sold primarily through its digital channels and Company-owned stores, as well as through various third-party arrangements. The Company’s two brand-based operating segments are Hollister, which includes the Company’s Hollister, Gilly Hicks, and Social Tourist brands, and Abercrombie, which includes the Company’s Abercrombie & Fitch and abercrombie kids brands. These five brands share a commitment to offering unique products of enduring quality and exceptional comfort that allow customers around the world to express their own individuality and style. The Company operates primarily in North America, Europe, and Asia.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Oct. 29, 2022
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of consolidation The accompanying Condensed Consolidated Financial Statements include historical financial statements of, and transactions applicable to, the Company and reflect its financial position, results of operations and cash flows. The Company has interests in an Emirati business venture and in a Kuwaiti business venture with Majid al Futtaim Fashion L.L.C. (“MAF”) and in a United States of America (the “U.S.”) business venture with Dixar L.L.C. (“Dixar”), each of which meets the definition of a variable interest entity (“VIE”). The purpose of the business ventures with MAF is to operate stores in the United Arab Emirates and Kuwait and the purpose of the business venture with Dixar is to hold the intellectual property related to the Social Tourist brand. The Company is deemed to be the primary beneficiary of these VIEs; therefore, the Company has consolidated the operating results, assets and liabilities of these VIEs, with the noncontrolling interests’ (“NCI”) portions of net (loss) income presented as net income attributable to NCI on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income and the NCI portion of stockholders’ equity presented as NCI on the Condensed Consolidated Balance Sheets. Fiscal year The Company’s fiscal year ends on the Saturday closest to January 31. This typically results in a fifty-two week year, but occasionally gives rise to an additional week, resulting in a fifty-three week year. Fiscal years are designated in the Condensed Consolidated Financial Statements and notes, as well as the remainder of this Quarterly Report on Form 10-Q, by the calendar year in which the fiscal year commences. All references herein to the Company’s fiscal years are as follows: Fiscal year Year ended/ ending Number of weeks Fiscal 2021 January 29, 2022 52 Fiscal 2022 January 28, 2023 52 Fiscal 2023 February 3, 2024 53 Interim financial statements The Condensed Consolidated Financial Statements as of October 29, 2022, and for the thirteen and thirty-nine week periods ended October 29, 2022 and October 30, 2021, are unaudited and are presented pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim consolidated financial statements. Accordingly, the Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and notes thereto contained in A&F’s Annual Report on Form 10-K for Fiscal 2021 filed with the SEC on March 28, 2022 (the “Fiscal 2021 Form 10-K”). The January 29, 2022 consolidated balance sheet data, included herein, were derived from audited consolidated financial statements, but do not include all disclosures required by accounting principles generally accepted in the U.S. (“GAAP”). In the opinion of management, the accompanying Condensed Consolidated Financial Statements reflect all adjustments (which are of a normal recurring nature) necessary to state fairly, in all material respects, the financial position, results of operations and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for Fiscal 2022. During the first quarter of 2022, the Company reclassified flagship store exit benefits into stores and distribution expense on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income. There were no changes to operating (loss) income or net (loss) income. Prior period amounts have been reclassified to conform to current year’s presentation. Use of estimates The preparation of financial statements, in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting period. Due to the inherent uncertainty involved with estimates, actual results may differ. Additionally, these estimates and assumptions may change as a result of the impact of global economic conditions such as the uncertainty regarding a slowing economy, rising interest rates, continued inflation, fluctuation in foreign exchange rates, the coronavirus ("COVID-19") pandemic, and the ongoing conflict in Ukraine and result in material impacts to the Company’s consolidated financial statements in future reporting periods. Recent accounting pronouncements The Company reviews recent accounting pronouncements on a quarterly basis and has excluded discussion of those not applicable to the Company and those that did not have, or are not expected to have, a material impact on the Company’s consolidated financial statements. Condensed Consolidated Statements of Cash Flows reconciliation The following table provides a reconciliation of cash and equivalents and restricted cash and equivalents to the amounts shown on the Condensed Consolidated Statements of Cash Flows: (in thousands) Location October 29, 2022 January 29, 2022 October 30, 2021 January 30, 2021 Cash and equivalents Cash and equivalents $ 257,332 $ 823,139 $ 865,622 $ 1,104,862 Long-term restricted cash and equivalents Other assets 9,674 11,229 11,401 14,814 Short-term restricted cash and equivalents Other current assets — — 3,280 4,481 Cash and equivalents and restricted cash and equivalents $ 267,006 $ 834,368 $ 880,303 $ 1,124,157
BASIS OF PRESENTATION	Interim financial statements The Condensed Consolidated Financial Statements as of October 29, 2022, and for the thirteen and thirty-nine week periods ended October 29, 2022 and October 30, 2021, are unaudited and are presented pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim consolidated financial statements. Accordingly, the Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and notes thereto contained in A&F’s Annual Report on Form 10-K for Fiscal 2021 filed with the SEC on March 28, 2022 (the “Fiscal 2021 Form 10-K”). The January 29, 2022 consolidated balance sheet data, included herein, were derived from audited consolidated financial statements, but do not include all disclosures required by accounting principles generally accepted in the U.S. (“GAAP”). In the opinion of management, the accompanying Condensed Consolidated Financial Statements reflect all adjustments (which are of a normal recurring nature) necessary to state fairly, in all material respects, the financial position, results of operations and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for Fiscal 2022. During the first quarter of 2022, the Company reclassified flagship store exit benefits into stores and distribution expense on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income. There were no changes to operating (loss) income or net (loss) income. Prior period amounts have been reclassified to conform to current year’s presentation.

Revenue Recognition (Notes)

Revenue Recognition (Notes)	9 Months Ended
	Oct. 29, 2022
Revenue Recognition [Abstract]
Revenue from Contract with Customer [Text Block]	REVENUE RECOGNITION Disaggregation of revenue All revenues are recognized in net sales in the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income. For information regarding the disaggregation of revenue, refer to Note 14, “ SEGMENT REPORTING . ” Contract liabilities The following table details certain contract liabilities representing unearned revenue as of October 29, 2022, January 29, 2022 and October 30, 2021: (in thousands) October 29, 2022 January 29, 2022 October 30, 2021 Gift card liability $ 35,016 $ 36,984 $ 30,815 Loyalty programs liability 22,930 22,757 21,964 The following table details recognized revenue associated with the Company’s gift card program and loyalty programs for the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Revenue associated with gift card redemptions and gift card breakage $ 21,194 $ 17,801 $ 66,847 $ 51,310 Revenue associated with reward redemptions and breakage related to the Company’s loyalty programs 11,767 12,075 32,578 31,525

Net Income (Loss) Per Share

Net Income (Loss) Per Share	9 Months Ended
	Oct. 29, 2022
Earnings Per Share [Abstract]
NET LOSS PER SHARE	NET (LOSS) INCOME PER SHARE Net (loss) income per basic and diluted share attributable to A&F is computed based on the weighted-average number of outstanding shares of Class A Common Stock (“Common Stock”). Additional information pertaining to net (loss) income per share attributable to A&F follows: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Shares of Common Stock issued 103,300 103,300 103,300 103,300 Weighted-average treasury shares (53,814) (44,504) (52,627) (42,421) Weighted-average — basic shares 49,486 58,796 50,673 60,879 Dilutive effect of share-based compensation awards — 2,669 — 2,891 Weighted-average — diluted shares 49,486 61,465 50,673 63,770 Anti-dilutive shares (1) 4,199 1,228 4,285 1,212 (1) Reflects the total number of shares related to outstanding share-based compensation awards that have been excluded from the computation of net (loss) income per diluted share because the impact would have been anti-dilutive. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can achieve up to 200% of their target vesting amount and are reflected at the maximum vesting amount less any dilutive portion.

Fair Value

Fair Value	9 Months Ended
	Oct. 29, 2022
Fair Value Disclosures [Abstract]
FAIR VALUE	FAIR VALUE Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The inputs used to measure fair value are prioritized based on a three-level hierarchy. The three levels of inputs to measure fair value are as follows: • Level 1—inputs are unadjusted quoted prices for identical assets or liabilities that are available in active markets that the Company can access at the measurement date. • Level 2—inputs are other than quoted market prices included within Level 1 that are observable for assets or liabilities, directly or indirectly. • Level 3—inputs to the valuation methodology are unobservable. The lowest level of significant input determines the placement of the entire fair value measurement in the hierarchy. The three levels of the hierarchy and the distribution of the Company’s assets measured at fair value on a recurring basis, as of October 29, 2022 and January 29, 2022, were as follows: Assets and Liabilities at Fair Value as of October 29, 2022 (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents (1) $ 51,722 $ — $ — $ 51,722 Derivative instruments (2) — 3,802 — 3,802 Rabbi Trust assets (3) 1 51,347 — 51,348 Restricted cash equivalents (1) 1,544 5,150 — 6,694 Total assets $ 53,267 $ 60,299 $ — $ 113,566 Liabilities: Derivative instruments (2) $ — $ 10 $ — $ 10 Total liabilities $ — $ 10 $ — $ 10 Assets at Fair Value as of January 29, 2022 (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents (1) $ 49,309 $ 11,643 $ — $ 60,952 Derivative instruments (2) — 4,973 — 4,973 Rabbi Trust assets (3) 1 62,272 — 62,273 Restricted cash equivalents (1) 5,391 2,326 — 7,717 Total assets $ 54,701 $ 81,214 $ — $ 135,915 (1) Level 1 assets consisted of investments in money market funds and U.S. treasury bills. Level 2 assets consisted of time deposits. (2) Level 2 assets consisted primarily of foreign currency exchange forward contracts. (3) Level 1 assets consisted of investments in money market funds. Level 2 assets consisted of trust-owned life insurance policies. The Company’s Level 2 assets consisted of: • Trust-owned life insurance policies, which were valued using the cash surrender value of the life insurance policies; • Time deposits, which were valued at cost, approximating fair value, due to the short-term nature of these investments; and • Derivative instruments, primarily foreign currency exchange forward contracts, which were valued using quoted market prices of the same or similar instruments, adjusted for counterparty risk. Fair value of long-term borrowings The Company’s borrowings under its senior secured notes, which have a fixed 8.75% interest rate and mature on July 15, 2025 (the “Senior Secured Notes”) are carried at historical cost in the accompanying Condensed Consolidated Balance Sheets. The carrying amount and fair value of the Company’s long-term gross borrowings were as follows: (in thousands) October 29, 2022 January 29, 2022 Gross borrowings outstanding, carrying amount $ 299,730 $ 307,730 Gross borrowings outstanding, fair value 283,245 327,732

Property and Equipment, Net

Property and Equipment, Net	9 Months Ended
	Oct. 29, 2022
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT, NET	PROPERTY AND EQUIPMENT, NET Property and equipment, net consisted of: (in thousands) October 29, 2022 January 29, 2022 Property and equipment, at cost $ 2,502,008 $ 2,453,493 Less: Accumulated depreciation and amortization (1,959,870) (1,945,157) Property and equipment, net $ 542,138 $ 508,336 R efer to Note 8, “ ASSET IMPAIRMENT ,” for details related to property and equipment impairment charges incurred during the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021.

Leases (Notes)

Leases (Notes)	9 Months Ended
	Oct. 29, 2022
Leases [Abstract]
Lessee, Operating Leases [Text Block]	LEASES The Company is a party to leases related to its Company-operated retail stores as well as for certain of its distribution centers, office space, information technology and equipment. The following table provides a summary of the Company’s operating lease costs for the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Single lease cost (1) $ 63,263 $ 66,969 $ 182,796 $ 207,046 Variable lease cost (2) 40,681 26,409 106,359 68,875 Operating lease right-of-use asset impairment (3) 1,205 5,512 4,693 8,216 Sublease income (4) (908) (1,068) (2,869) (3,256) Total operating lease cost $ 104,241 $ 97,822 $ 290,979 $ 280,881 (1) Included amortization and interest expense associated with operating lease right-of-use assets and the impact from remeasurement of operating lease liabilities. (2) Includes variable payments related to both lease and nonlease components, such as contingent rent payments made by the Company based on performance, and payments related to taxes, insurance, and maintenance costs, as well as the benefit of $0.8 million and $3.3 million of rent abatements during the thirteen and thirty-nine weeks ended October 29, 2022, respectively, related to the effects of the COVID-19 pandemic that resulted in the total payments required by the modified contract being substantially the same as or less than total payments required by the original contract. The benefit related to rent abatements recognized during the thirteen and thirty-nine weeks ended October 30, 2021 was $1.7 million and $14.6 million respectively. (3) Refer to Note 8, “ ASSET IMPAIRMENT ,” for details related to operating lease right-of-use asset impairment charges. (4) The terms of the sublease agreement entered into by the Company with a third party during Fiscal 2020 related to one of its previous flagship store locations have not changed materially from that disclosed in Note 8, “LEASES,” of the Notes to Consolidated Financial Statements contained in “Item 8. Financial Statements and Supplementary Data” of the Fiscal 2021 Form 10-K. Sublease income is recognized in other operating income, net on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income. The Company had minimum commitments related to operating lease contracts that have not yet commenced, primarily for its Company-operated retail stores, of approximately $31.5 million as of October 29, 2022.

Asset Impairment (Notes)

Asset Impairment (Notes)	9 Months Ended
	Oct. 29, 2022
Asset Impairment [Abstract]
Asset Impairment Charges [Text Block]	ASSET IMPAIRMENT Asset impairment charges for the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021 were as follows: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Operating lease right-of-use asset impairment $ 1,205 $ 5,512 $ 4,693 $ 8,216 Property and equipment asset impairment (1) 2,539 1,237 4,643 1,983 Total asset impairment $ 3,744 $ 6,749 $ 9,336 $ 10,199 (1) Amounts include $0.6 million of store asset impairment and $1.9 million other asset impairment for the thirteen weeks ended October 29, 2022 and $2.7 million of store asset impairment and $1.9 million other asset impairment for the thirty-nine weeks ended October 29, 2022. Amounts for the thirteen and thirty-nine weeks ended October 30, 2021 only include store asset impairment. Asset impairment charges for the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021 related to certain of the Company’s assets including stores across brands, geographies and store formats and other assets. The store impairment charges for the thirty-nine weeks ended October 29, 2022 reduced the then carrying amount of the impaired stores’ assets to their fair value of approximately $38.7 million, including $37.8 million related to operating lease right-of-use assets. The impairment charges for the thirty-nine weeks ended October 30, 2021 reduced the then carrying amount of the impaired stores’ assets to their fair value of approximately $19.5 million, including $17.0 million related to operating lease right-of-use assets.

Income Taxes

Income Taxes	9 Months Ended
	Oct. 29, 2022
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The quarterly provision for income taxes is based on the current estimate of the annual effective income tax rate and the tax effect of discrete items occurring during the quarter. The Company’s quarterly provision and the estimate of the annual effective tax rate are subject to significant variation due to several factors. These factors include variability in the pre-tax jurisdictional mix of earnings, changes in how the Company does business including entering into new businesses or geographies, changes in foreign currency exchange rates, changes in laws, regulations, interpretations and administrative practices, relative changes in expenses or losses for which tax benefits are not recognized and the impact of discrete items. In addition, jurisdictions where the Company anticipates an ordinary loss for the fiscal year for which the Company does not anticipate future tax benefits are excluded from the overall computation of estimated annual effective tax rate and no tax benefits are recognized in the period related to losses in such jurisdictions. The impact of these items on the effective tax rate will be greater at lower levels of pre-tax earnings. On August 16, 2022, the Inflation Reduction Act of 2022 (the “Inflation Reduction Act”) was enacted into law. The Company does not currently expect that the Inflation Reduction Act will have a material impact on its income taxes. Impact of valuation allowances and other tax charges During the thirteen and thirty-nine weeks ended October 29, 2022, the Company did not recognize income tax benefits on $30.0 million and $69.7 million, respectively, of pretax losses, primarily in Switzerland, resulting in adverse tax impacts of $5.6 million and $12.8 million, respectively. As of October 29, 2022, there were approximately $11.2 million of net deferred tax assets in China. The realization of these net deferred tax assets is dependent upon the future generation of sufficient taxable profits in China. During the thirty-nine weeks ended October 29, 2022, the company recorded a $0.2 million valuation allowance on net operating losses currently not projected to be utilized in future years. While the Company believes that the remaining net deferred tax assets are more-likely-than-not to be realized, it is not a certainty, as the Company continues to evaluate and respond to certain situations, such as the COVID-19 pandemic. The Company is closely monitoring its operations in China. Should circumstances change, the net deferred tax assets may become subject to additional valuation allowances in the future. Additional valuation allowances would result in additional tax expense. During the thirteen weeks ended October 30, 2021, the Company recognized $3.5 million of tax benefits due to the expected utilization of deferred tax assets against projected pre-tax income for the full fiscal year, primarily in the U.S. and Germany, based on information available, on which a valuation allowance had previously been established. During the thirty-nine weeks ended October 30, 2021, the Company recognized $23.4 million of discrete tax benefits due to the release of valuation allowances, primarily in the U.S. and Germany, and a discrete tax benefit of $3.9 million due to a rate change in the U.K. The Company also recognized $13.6 million of tax benefits due to the expected utilization of deferred tax assets against projected pre-tax income for the full fiscal year, primarily in the U.S. and Germany, based on information available, on which a valuation allowance had previously been established. The Company continues to maintain valuation allowances in certain jurisdictions, principally Switzerland and Japan. Share-based compensation Refer to Note 11, “ SHARE-BASED COMPENSATION ,” for details on income tax benefits and charges related to share-based compensation awards during the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021.

Borrowings

Borrowings	9 Months Ended
	Oct. 29, 2022
Debt Disclosure [Abstract]
Borrowings	BORROWINGS Details on the Company’s long-term borrowings, net, as of October 29, 2022 and January 29, 2022 are as follows: (in thousands) October 29, 2022 January 29, 2022 Long-term portion of borrowings, gross at carrying amount $ 299,730 $ 307,730 Unamortized fees (3,198) (4,156) Long-term borrowings, net $ 296,532 $ 303,574 Senior Secured Notes During the thirteen weeks ended October 29, 2022, Abercrombie & Fitch Management Co.(“A&F Management”), a wholly-owned indirect subsidiary of A&F, purchased $8.0 million of outstanding Senior Secured Notes and incurred a $0.1 million gain on extinguishment of debt, recognized in interest expense, net on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income. The terms of the Senior Secured Notes have remained unchanged from those disclosed in Note 13, “BORROWINGS,” of the Notes to Consolidated Financial Statements contained in “Item 8. Financial Statements and Supplementary Data” of on the Fiscal 2021 Form 10-K. ABL Facility The terms of the Company’s senior secured revolving credit facility of up to $400.0 million (the “ABL Facility”) have remained unchanged from those disclosed in Note 13, “BORROWINGS,” of the Notes to Consolidated Financial Statements contained in “Item 8. Financial Statements and Supplementary Dat a ” of the Fiscal 2021 Form 10-K. The Company did not have any borrowings outstanding under the ABL Facility as of October 29, 2022 or as of January 29, 2022. As of October 29, 2022, availability under the ABL Facility was $399.4 million, net of $0.6 million in outstanding stand-by letters of credit. As the Company must maintain excess availability equal to the greater of 10% of the loan cap or $30 million under the ABL Facility, borrowing capacity available to the Company under the ABL Facility was $359.4 million as of October 29, 2022. Representations, warranties and covenants The agreements related to the Senior Secured Notes and the ABL Facility contain various representations, warranties and restrictive covenants that, among other things and subject to specified exceptions, restrict the ability of the Company and its subsidiaries to: grant or incur liens; incur, assume or guarantee additional indebtedness; sell or otherwise dispose of assets, including capital stock of subsidiaries; make investments in certain subsidiaries; pay dividends, make distributions or redeem or repurchase capital stock; change the nature of their business; and consolidate or merge with or into, or sell substantially all of the assets of the Company or A&F Management to another entity. The Senior Secured Notes are guaranteed on a senior secured basis, jointly and severally, by A&F and each of the existing and future wholly-owned domestic restricted subsidiaries of A&F that guarantee or will guarantee A&F Management’s Amended and Restated Credit Agreement (the “Amended and Restated Credit Agreement”) or certain future capital markets indebtedness. Certain of the agreements related to the Senior Secured Notes and the ABL Facility also contain certain affirmative covenants, including reporting requirements such as delivery of financial statements, certificates and notices of certain events, maintaining insurance and providing additional guarantees and collateral in certain circumstances. The Company was in compliance with all debt covenants under these agreements as of October 29, 2022.

Share-Based Compensation

Share-Based Compensation	9 Months Ended
	Oct. 29, 2022
Share-based Payment Arrangement [Abstract]
SHARE-BASED COMPENSATION	SHARE-BASED COMPENSATION Financial statement impact The following table details share-based compensation expense and the related income tax impacts for the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Share-based compensation expense $ 7,310 $ 7,332 $ 23,426 $ 22,269 Income tax benefit associated with share-based compensation expense recognized 635 806 2,615 2,492 The following table details discrete income tax benefits and charges related to share-based compensation awards during the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Income tax discrete (charges) benefits realized for tax deductions related to the issuance of shares $ (29) $ 150 $ 1,970 $ 4,166 Income tax discrete (charges) benefits realized upon cancellation of stock appreciation rights (10) — (213) (3) Total income tax discrete (charges) benefits related to share-based compensation awards $ (39) $ 150 $ 1,757 $ 4,163 The following table details the amount of employee tax withheld by the Company upon the issuance of shares associated with restricted stock units vesting and the exercise of stock appreciation rights for the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Employee tax withheld upon issuance of shares (1) $ 426 $ 984 $ 14,432 $ 13,044 (1) Classified within other financing activities on the Condensed Consolidated Statements of Cash Flows. Restricted stock units The following table summarizes activity for restricted stock units for the thirty-nine weeks ended October 29, 2022: Service-based Restricted Performance-based Restricted Market-based Restricted Number of Weighted- Number of Weighted- Number of Weighted- Unvested at January 29, 2022 2,532,240 $ 17.16 340,149 $ 27.08 680,184 $ 22.81 Granted 983,139 28.73 185,197 30.24 92,603 41.60 Adjustments for performance achievement — — 5,668 23.05 18,881 36.24 Vested (927,346) 18.01 (194,465) 23.05 (113,284) 36.24 Forfeited (136,982) 20.37 — — (16,247) 16.24 Unvested at October 29, 2022 (1) 2,451,051 $ 21.30 336,549 $ 31.08 662,137 $ 23.68 (1) Unvested shares related to restricted stock units with performance-based and market-based vesting conditions are reflected at 100% of their target vesting amount in the table above. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can be achieved at up to 200% of their target vesting amount. The following table details unrecognized compensation cost and the remaining weighted-average period over which these costs are expected to be recognized for restricted stock units as of October 29, 2022: (in thousands) Service-based Restricted Performance-based Restricted Market-based Restricted Unrecognized compensation cost $ 39,040 $ — $ 15,602 Remaining weighted-average period cost is expected to be recognized (years) 1.3 0.0 0.9 Additional information pertaining to restricted stock units for the thirty-nine weeks ended October 29, 2022 and October 30, 2021 follows: (in thousands) October 29, 2022 October 30, 2021 Service-based restricted stock units: Total grant date fair value of awards granted $ 28,246 $ 23,760 Total grant date fair value of awards vested 16,702 13,232 Performance-based restricted stock units: Total grant date fair value of awards granted 5,600 5,059 Total grant date fair value of awards vested 4,482 — Market-based restricted stock units: Total grant date fair value of awards granted 3,852 4,492 Total grant date fair value of awards vested 4,105 3,390 The weighted-average assumptions used for market-based restricted stock units in the Monte Carlo simulation during the thirty-nine weeks ended October 29, 2022 and October 30, 2021 were as follows: October 29, 2022 October 30, 2021 Grant date market price $ 30.24 $ 36.15 Fair value 41.60 56.99 Price volatility 66 % 65 % Expected term (years) 2.8 2.5 Risk-free interest rate 2.5 % 0.3 % Dividend yield — — Average volatility of peer companies 72.3 76.0 Average correlation coefficient of peer companies 0.5150 0.5130 Stock appreciation rights The following table summarizes stock appreciation rights activity for the thirty-nine weeks ended October 29, 2022: Number of Weighted-Average Aggregate Weighted-Average Outstanding at January 29, 2022 236,139 $ 32.55 Forfeited or expired (37,800) 48.72 Outstanding at October 29, 2022 198,339 $ 29.47 $ — 1.9 Stock appreciation rights exercisable at October 29, 2022 198,339 $ 29.47 $ — 1.9

Derivative Instruments

Derivative Instruments	9 Months Ended
	Oct. 29, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE INSTRUMENTS	DERIVATIVE INSTRUMENTS The Company is exposed to risks associated with changes in foreign currency exchange rates and uses derivative instruments, primarily forward contracts, to manage the financial impacts of these exposures. The Company does not use forward contracts to engage in currency speculation and does not enter into derivative financial instruments for trading purposes. The Company uses derivative instruments, primarily foreign currency exchange forward contracts designated as cash flow hedges, to hedge the foreign currency exchange rate exposure associated with forecasted foreign-currency-denominated intercompany inventory sales to foreign subsidiaries and the related settlement of the foreign-currency-denominated intercompany receivables. Fluctuations in foreign currency exchange rates will either increase or decrease the Company’s intercompany equivalent cash flows and affect the Company’s U.S. Dollar earnings. Gains or losses on the foreign currency exchange forward contracts that are used to hedge these exposures are expected to partially offset this variability. Foreign currency exchange forward contracts represent agreements to exchange the currency of one country for the currency of another country at an agreed upon settlement date. These foreign currency exchange forward contracts typically have a maximum term of twelve months. The sale of the inventory to the Company’s customers will result in the reclassification of related derivative gains and losses that are reported in AOCL into earnings. The Company also uses foreign currency exchange forward contracts to hedge certain foreign-currency-denominated net monetary assets/liabilities. Examples of monetary assets/liabilities include cash balances, receivables and payables. Fluctuations in foreign currency exchange rates result in transaction gains or losses being recorded in earnings, as GAAP requires that monetary assets/liabilities be remeasured at the spot exchange rate at quarter-end and upon settlement. The Company has chosen not to apply hedge accounting to these instruments because there are no anticipated differences in the timing of gain or loss recognition on the hedging instruments and the hedged items. As of October 29, 2022, the Company had outstanding the following foreign currency exchange forward contracts that were entered into to hedge either a portion, or all, of forecasted foreign-currency-denominated intercompany inventory transactions, the resulting settlement of the foreign-currency-denominated intercompany accounts receivable, or both: (in thousands) Notional Amount (1) Euro $ 50,728 British pound 58,382 Canadian dollar 2,232 Japanese yen 2,254 (1) Amounts reported are the U.S. Dollar notional amounts outstanding as of October 29, 2022. The fair value of derivative instruments is valued using quoted market prices of the same or similar instruments, adjusted for counterparty risk. The location and amounts of derivative fair values of foreign currency exchange forward contracts on the Condensed Consolidated Balance Sheets as of October 29, 2022 and January 29, 2022 were as follows: (in thousands) Location October 29, 2022 January 29, 2022 Location October 29, 2022 January 29, 2022 Derivatives designated as cash flow hedging instruments Other current assets $ 3,802 $ 4,973 Accrued expenses $ 10 $ — Derivatives not designated as hedging instruments Other current assets — — Accrued expenses — — Total $ 3,802 $ 4,973 $ 10 $ — Information pertaining to derivative gains or losses from foreign currency exchange forward contracts designated as cash flow hedging instruments for the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021 follows: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Gain recognized in AOCL (1) $ 2,723 $ 4,589 $ 10,447 $ 6,818 Gain (loss) reclassified from AOCL to cost of sales, exclusive of depreciation and amortization (2) 3,909 141 $ 11,718 $ (3,010) (1) Amount represents the change in fair value of derivative instruments. (2) Amount represents gain (loss) reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) when the hedged item affects earnings, which is when merchandise is converted to cost of sales, exclusive of depreciation and amortization. Substantially all of the unrealized gain will be recognized in costs of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income over the next twelve months. Additional information pertaining to derivative gains or losses from foreign currency exchange forward contracts not designated as hedging instruments for the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021 follows: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Gain recognized in other operating income, net $ 504 $ 487 $ 2,276 $ 324

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	9 Months Ended
	Oct. 29, 2022
Equity [Abstract]
ACCUMULATED OTHER COMPREHENSIVE LOSS	r the thirteen and thirty-nine weeks ended October 29, 2022, the activity in AOCL was as follows: Thirteen Weeks Ended October 29, 2022 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at July 30, 2022 $ (136,006) $ 5,966 $ (130,040) Other comprehensive (loss) income before reclassifications (11,021) 2,723 (8,298) Reclassified gain from AOCL (1) — (3,909) (3,909) Tax effect — (20) (20) Other comprehensive loss after reclassifications (11,021) (1,206) (12,227) Ending balance at October 29, 2022 $ (147,027) $ 4,760 $ (142,267) Thirty-Nine Weeks Ended October 29, 2022 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at January 29, 2022 $ (120,689) $ 5,983 $ (114,706) Other comprehensive (loss) income before reclassifications (26,338) 10,447 (15,891) Reclassified gain from AOCL (1) — (11,718) (11,718) Tax effect — 48 48 Other comprehensive loss after reclassifications (26,338) (1,223) (27,561) Ending balance at October 29, 2022 $ (147,027) $ 4,760 $ (142,267) (1) Amount represents gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income. For the thirteen and thirty-nine weeks ended October 30, 2021, the activity in AOCL was as follows: Thirteen Weeks Ended October 30, 2021 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at July 31, 2021 $ (101,032) $ 767 $ (100,265) Other comprehensive (loss) income before reclassifications (5,629) 4,589 (1,040) Reclassified gain from AOCL (1) — (141) (141) Tax effect — (32) (32) Other comprehensive (loss) income after reclassifications (5,629) 4,416 (1,213) Ending balance at October 30, 2021 $ (106,661) $ 5,183 $ (101,478) Thirty-Nine Weeks Ended October 30, 2021 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at January 30, 2021 $ (97,772) $ (4,535) $ (102,307) Other comprehensive (loss) income before reclassifications (8,889) 6,818 (2,071) Reclassified loss from AOCL (1) — 3,010 3,010 Tax effect — (110) (110) Other comprehensive (loss) income after reclassifications (8,889) 9,718 829 Ending balance at October 30, 2021 $ (106,661) $ 5,183 $ (101,478) (1) Amount represents loss reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income.

Segment Reporting

Segment Reporting	9 Months Ended
	Oct. 29, 2022
Segment Reporting [Abstract]
SEGMENT REPORTING	SEGMENT REPORTING The Company’s two operating segments are brand-based: Hollister, which includes the Company’s Hollister, Gilly Hicks and Social Tourist brands, and Abercrombie, which includes the Company’s Abercrombie & Fitch and abercrombie kids brands. These operating segments have similar economic characteristics, classes of consumers, products, and production and distribution methods, operate in the same regulatory environments, and have been aggregated into one reportable segment. Amounts shown below include net sales from wholesale, franchise and licensing operations, which are not a significant component of total revenue, and are aggregated within their respective operating segment and geographic area. The Company’s net sales by operating segment for the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021 were as follows: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Hollister $ 457,752 $ 522,311 $ 1,323,492 $ 1,479,202 Abercrombie 422,332 382,849 1,174,445 1,072,213 Total $ 880,084 $ 905,160 $ 2,497,937 $ 2,551,415 Net sales by geographic area are presented by attributing revenues to an individual country on the basis of the country in which the merchandise was sold for in-store purchases and on the basis of the shipping location provided by customers for digital and wholesale orders. The Company’s net sales by geographic area for the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021 were as follows: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 U.S. $ 674,555 $ 654,858 $ 1,837,760 $ 1,810,471 EMEA (1) 139,826 179,156 470,575 528,998 APAC (2) 28,293 38,215 85,968 125,489 Other (3) 37,410 32,931 103,634 86,457 International $ 205,529 $ 250,302 $ 660,177 $ 740,944 Total $ 880,084 $ 905,160 $ 2,497,937 $ 2,551,415 (1) Europe, Middle East and Africa (“EMEA”). (2) Asia-Pacific Region (“APAC”). (3) Other includes all sales that do not fall within the United States, EMEA, or APAC regions, which are derived primarily in Canada.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 29, 2022
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of consolidation The accompanying Condensed Consolidated Financial Statements include historical financial statements of, and transactions applicable to, the Company and reflect its financial position, results of operations and cash flows. The Company has interests in an Emirati business venture and in a Kuwaiti business venture with Majid al Futtaim Fashion L.L.C. (“MAF”) and in a United States of America (the “U.S.”) business venture with Dixar L.L.C. (“Dixar”), each of which meets the definition of a variable interest entity (“VIE”). The purpose of the business ventures with MAF is to operate stores in the United Arab Emirates and Kuwait and the purpose of the business venture with Dixar is to hold the intellectual property related to the Social Tourist brand. The Company is deemed to be the primary beneficiary of these VIEs; therefore, the Company has consolidated the operating results, assets and liabilities of these VIEs, with the noncontrolling interests’ (“NCI”) portions of net (loss) income presented as net income attributable to NCI on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income and the NCI portion of stockholders’ equity presented as NCI on the Condensed Consolidated Balance Sheets.
Fiscal Period, Policy [Policy Text Block]	Fiscal year The Company’s fiscal year ends on the Saturday closest to January 31. This typically results in a fifty-two week year, but occasionally gives rise to an additional week, resulting in a fifty-three week year. Fiscal years are designated in the Condensed Consolidated Financial Statements and notes, as well as the remainder of this Quarterly Report on Form 10-Q, by the calendar year in which the fiscal year commences. All references herein to the Company’s fiscal years are as follows: Fiscal year Year ended/ ending Number of weeks Fiscal 2021 January 29, 2022 52 Fiscal 2022 January 28, 2023 52 Fiscal 2023 February 3, 2024 53

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Oct. 29, 2022
Accounting Policies [Abstract]
Reconciliation of Cash and Equivalents to Restricted cash and Equivalents [Table Text Block]	Condensed Consolidated Statements of Cash Flows reconciliation The following table provides a reconciliation of cash and equivalents and restricted cash and equivalents to the amounts shown on the Condensed Consolidated Statements of Cash Flows: (in thousands) Location October 29, 2022 January 29, 2022 October 30, 2021 January 30, 2021 Cash and equivalents Cash and equivalents $ 257,332 $ 823,139 $ 865,622 $ 1,104,862 Long-term restricted cash and equivalents Other assets 9,674 11,229 11,401 14,814 Short-term restricted cash and equivalents Other current assets — — 3,280 4,481 Cash and equivalents and restricted cash and equivalents $ 267,006 $ 834,368 $ 880,303 $ 1,124,157

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Oct. 29, 2022
Revenue Recognition [Abstract]
Deferred Revenue, by Arrangement, Disclosure [Table Text Block]	The following table details certain contract liabilities representing unearned revenue as of October 29, 2022, January 29, 2022 and October 30, 2021: (in thousands) October 29, 2022 January 29, 2022 October 30, 2021 Gift card liability $ 35,016 $ 36,984 $ 30,815 Loyalty programs liability 22,930 22,757 21,964 The following table details recognized revenue associated with the Company’s gift card program and loyalty programs for the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Revenue associated with gift card redemptions and gift card breakage $ 21,194 $ 17,801 $ 66,847 $ 51,310 Revenue associated with reward redemptions and breakage related to the Company’s loyalty programs 11,767 12,075 32,578 31,525

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Table)	9 Months Ended
	Oct. 29, 2022
Earnings Per Share [Abstract]
Schedule of Weighted Average Number of Shares	Additional information pertaining to net (loss) income per share attributable to A&F follows: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Shares of Common Stock issued 103,300 103,300 103,300 103,300 Weighted-average treasury shares (53,814) (44,504) (52,627) (42,421) Weighted-average — basic shares 49,486 58,796 50,673 60,879 Dilutive effect of share-based compensation awards — 2,669 — 2,891 Weighted-average — diluted shares 49,486 61,465 50,673 63,770 Anti-dilutive shares (1) 4,199 1,228 4,285 1,212 (1) Reflects the total number of shares related to outstanding share-based compensation awards that have been excluded from the computation of net (loss) income per diluted share because the impact would have been anti-dilutive. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can achieve up to 200% of their target vesting amount and are reflected at the maximum vesting amount less any dilutive portion.

Fair Value (Tables)

Fair Value (Tables)	9 Months Ended
	Oct. 29, 2022
Fair Value Disclosures [Abstract]
Company's Assets and Liabilities Measured at Fair Value	The three levels of the hierarchy and the distribution of the Company’s assets measured at fair value on a recurring basis, as of October 29, 2022 and January 29, 2022, were as follows: Assets and Liabilities at Fair Value as of October 29, 2022 (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents (1) $ 51,722 $ — $ — $ 51,722 Derivative instruments (2) — 3,802 — 3,802 Rabbi Trust assets (3) 1 51,347 — 51,348 Restricted cash equivalents (1) 1,544 5,150 — 6,694 Total assets $ 53,267 $ 60,299 $ — $ 113,566 Liabilities: Derivative instruments (2) $ — $ 10 $ — $ 10 Total liabilities $ — $ 10 $ — $ 10 Assets at Fair Value as of January 29, 2022 (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents (1) $ 49,309 $ 11,643 $ — $ 60,952 Derivative instruments (2) — 4,973 — 4,973 Rabbi Trust assets (3) 1 62,272 — 62,273 Restricted cash equivalents (1) 5,391 2,326 — 7,717 Total assets $ 54,701 $ 81,214 $ — $ 135,915 (1) Level 1 assets consisted of investments in money market funds and U.S. treasury bills. Level 2 assets consisted of time deposits. (2) Level 2 assets consisted primarily of foreign currency exchange forward contracts.
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Valuation Techniques [Table Text Block]	The carrying amount and fair value of the Company’s long-term gross borrowings were as follows: (in thousands) October 29, 2022 January 29, 2022 Gross borrowings outstanding, carrying amount $ 299,730 $ 307,730 Gross borrowings outstanding, fair value 283,245 327,732

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	9 Months Ended
	Oct. 29, 2022
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and equipment, net consisted of: (in thousands) October 29, 2022 January 29, 2022 Property and equipment, at cost $ 2,502,008 $ 2,453,493 Less: Accumulated depreciation and amortization (1,959,870) (1,945,157) Property and equipment, net $ 542,138 $ 508,336 R efer to Note 8, “ ASSET IMPAIRMENT ,” for details related to property and equipment impairment charges incurred during the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021.

Leases (Tables)

Leases (Tables)	9 Months Ended
	Oct. 29, 2022
Leases [Abstract]
Lease, Cost [Table Text Block]	The following table provides a summary of the Company’s operating lease costs for the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Single lease cost (1) $ 63,263 $ 66,969 $ 182,796 $ 207,046 Variable lease cost (2) 40,681 26,409 106,359 68,875 Operating lease right-of-use asset impairment (3) 1,205 5,512 4,693 8,216 Sublease income (4) (908) (1,068) (2,869) (3,256) Total operating lease cost $ 104,241 $ 97,822 $ 290,979 $ 280,881 (1) Included amortization and interest expense associated with operating lease right-of-use assets and the impact from remeasurement of operating lease liabilities. (2) Includes variable payments related to both lease and nonlease components, such as contingent rent payments made by the Company based on performance, and payments related to taxes, insurance, and maintenance costs, as well as the benefit of $0.8 million and $3.3 million of rent abatements during the thirteen and thirty-nine weeks ended October 29, 2022, respectively, related to the effects of the COVID-19 pandemic that resulted in the total payments required by the modified contract being substantially the same as or less than total payments required by the original contract. The benefit related to rent abatements recognized during the thirteen and thirty-nine weeks ended October 30, 2021 was $1.7 million and $14.6 million respectively. (3) Refer to Note 8, “ ASSET IMPAIRMENT ,” for details related to operating lease right-of-use asset impairment charges. (4) The terms of the sublease agreement entered into by the Company with a third party during Fiscal 2020 related to one of its previous flagship store locations have not changed materially from that disclosed in Note 8, “LEASES,” of the Notes to Consolidated Financial Statements contained in “Item 8. Financial Statements and Supplementary Data” of the Fiscal 2021 Form 10-K. Sublease income is recognized in other operating income, net on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income.

Asset Impairment (Tables)

Asset Impairment (Tables)	9 Months Ended
	Oct. 29, 2022
Asset Impairment [Abstract]
Impaired Assets to be Disposed of by Method Other than Sale [Table Text Block]	Asset impairment charges for the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021 were as follows: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Operating lease right-of-use asset impairment $ 1,205 $ 5,512 $ 4,693 $ 8,216 Property and equipment asset impairment (1) 2,539 1,237 4,643 1,983 Total asset impairment $ 3,744 $ 6,749 $ 9,336 $ 10,199 (1) Amounts include $0.6 million of store asset impairment and $1.9 million other asset impairment for the thirteen weeks ended October 29, 2022 and $2.7 million of store asset impairment and $1.9 million other asset impairment for the thirty-nine weeks ended October 29, 2022. Amounts for the thirteen and thirty-nine weeks ended October 30, 2021 only include store asset impairment.

Borrowings (Tables)

Borrowings (Tables)	9 Months Ended
	Oct. 29, 2022
Debt Disclosure [Abstract]
Schedule of Borrowings	Details on the Company’s long-term borrowings, net, as of October 29, 2022 and January 29, 2022 are as follows: (in thousands) October 29, 2022 January 29, 2022 Long-term portion of borrowings, gross at carrying amount $ 299,730 $ 307,730 Unamortized fees (3,198) (4,156) Long-term borrowings, net $ 296,532 $ 303,574

Share-Based Compensation (Table

Share-Based Compensation (Tables)	9 Months Ended
	Oct. 29, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	The following table details share-based compensation expense and the related income tax impacts for the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Share-based compensation expense $ 7,310 $ 7,332 $ 23,426 $ 22,269 Income tax benefit associated with share-based compensation expense recognized 635 806 2,615 2,492
Share-based Payment Arrangement, Discrete Tax Benefit (Charge) [Table Text Block]	The following table details discrete income tax benefits and charges related to share-based compensation awards during the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Income tax discrete (charges) benefits realized for tax deductions related to the issuance of shares $ (29) $ 150 $ 1,970 $ 4,166 Income tax discrete (charges) benefits realized upon cancellation of stock appreciation rights (10) — (213) (3) Total income tax discrete (charges) benefits related to share-based compensation awards $ (39) $ 150 $ 1,757 $ 4,163
Employee tax withheld by company for share-based compensation	The following table details the amount of employee tax withheld by the Company upon the issuance of shares associated with restricted stock units vesting and the exercise of stock appreciation rights for the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Employee tax withheld upon issuance of shares (1) $ 426 $ 984 $ 14,432 $ 13,044 (1) Classified within other financing activities on the Condensed Consolidated Statements of Cash Flows.
Schedule of Restricted Stock Unit Activity	The following table summarizes activity for restricted stock units for the thirty-nine weeks ended October 29, 2022: Service-based Restricted Performance-based Restricted Market-based Restricted Number of Weighted- Number of Weighted- Number of Weighted- Unvested at January 29, 2022 2,532,240 $ 17.16 340,149 $ 27.08 680,184 $ 22.81 Granted 983,139 28.73 185,197 30.24 92,603 41.60 Adjustments for performance achievement — — 5,668 23.05 18,881 36.24 Vested (927,346) 18.01 (194,465) 23.05 (113,284) 36.24 Forfeited (136,982) 20.37 — — (16,247) 16.24 Unvested at October 29, 2022 (1) 2,451,051 $ 21.30 336,549 $ 31.08 662,137 $ 23.68 (1) Unvested shares related to restricted stock units with performance-based and market-based vesting conditions are reflected at 100% of their target vesting amount in the table above. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can be achieved at up to 200% of their target vesting amount.
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award	The following table details unrecognized compensation cost and the remaining weighted-average period over which these costs are expected to be recognized for restricted stock units as of October 29, 2022: (in thousands) Service-based Restricted Performance-based Restricted Market-based Restricted Unrecognized compensation cost $ 39,040 $ — $ 15,602 Remaining weighted-average period cost is expected to be recognized (years) 1.3 0.0 0.9
Schedule of Stock Appreciation Rights Activity	The following table summarizes stock appreciation rights activity for the thirty-nine weeks ended October 29, 2022: Number of Weighted-Average Aggregate Weighted-Average Outstanding at January 29, 2022 236,139 $ 32.55 Forfeited or expired (37,800) 48.72 Outstanding at October 29, 2022 198,339 $ 29.47 $ — 1.9 Stock appreciation rights exercisable at October 29, 2022 198,339 $ 29.47 $ — 1.9
Market-based restricted stock units [Member]
Schedule of Weighted-Average Estimated Fair Value and Assumptions of Restricted Stock Units with Market Vesting Conditions	Additional information pertaining to restricted stock units for the thirty-nine weeks ended October 29, 2022 and October 30, 2021 follows: (in thousands) October 29, 2022 October 30, 2021 Service-based restricted stock units: Total grant date fair value of awards granted $ 28,246 $ 23,760 Total grant date fair value of awards vested 16,702 13,232 Performance-based restricted stock units: Total grant date fair value of awards granted 5,600 5,059 Total grant date fair value of awards vested 4,482 — Market-based restricted stock units: Total grant date fair value of awards granted 3,852 4,492 Total grant date fair value of awards vested 4,105 3,390 The weighted-average assumptions used for market-based restricted stock units in the Monte Carlo simulation during the thirty-nine weeks ended October 29, 2022 and October 30, 2021 were as follows: October 29, 2022 October 30, 2021 Grant date market price $ 30.24 $ 36.15 Fair value 41.60 56.99 Price volatility 66 % 65 % Expected term (years) 2.8 2.5 Risk-free interest rate 2.5 % 0.3 % Dividend yield — — Average volatility of peer companies 72.3 76.0 Average correlation coefficient of peer companies 0.5150 0.5130

Derivative Instruments (Tables)

Derivative Instruments (Tables)	9 Months Ended
	Oct. 29, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Outstanding Foreign Exchange Forward Contracts	As of October 29, 2022, the Company had outstanding the following foreign currency exchange forward contracts that were entered into to hedge either a portion, or all, of forecasted foreign-currency-denominated intercompany inventory transactions, the resulting settlement of the foreign-currency-denominated intercompany accounts receivable, or both: (in thousands) Notional Amount (1) Euro $ 50,728 British pound 58,382 Canadian dollar 2,232 Japanese yen 2,254 (1) Amounts reported are the U.S. Dollar notional amounts outstanding as of October 29, 2022.
Location and Amounts of Derivative Fair Values on the Condensed Consolidated Balance Sheets	The fair value of derivative instruments is valued using quoted market prices of the same or similar instruments, adjusted for counterparty risk. The location and amounts of derivative fair values of foreign currency exchange forward contracts on the Condensed Consolidated Balance Sheets as of October 29, 2022 and January 29, 2022 were as follows: (in thousands) Location October 29, 2022 January 29, 2022 Location October 29, 2022 January 29, 2022 Derivatives designated as cash flow hedging instruments Other current assets $ 3,802 $ 4,973 Accrued expenses $ 10 $ — Derivatives not designated as hedging instruments Other current assets — — Accrued expenses — — Total $ 3,802 $ 4,973 $ 10 $ —
Location and Amounts of Derivative Gains and Losses on the Condensed Consolidated Statements of Operations and Comprehensive Loss	Information pertaining to derivative gains or losses from foreign currency exchange forward contracts designated as cash flow hedging instruments for the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021 follows: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Gain recognized in AOCL (1) $ 2,723 $ 4,589 $ 10,447 $ 6,818 Gain (loss) reclassified from AOCL to cost of sales, exclusive of depreciation and amortization (2) 3,909 141 $ 11,718 $ (3,010) (1) Amount represents the change in fair value of derivative instruments. (2) Amount represents gain (loss) reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) when the hedged item affects earnings, which is when merchandise is converted to cost of sales, exclusive of depreciation and amortization. Substantially all of the unrealized gain will be recognized in costs of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income over the next twelve months. Additional information pertaining to derivative gains or losses from foreign currency exchange forward contracts not designated as hedging instruments for the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021 follows: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Gain recognized in other operating income, net $ 504 $ 487 $ 2,276 $ 324

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
	Oct. 29, 2022
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Loss	For the thirteen and thirty-nine weeks ended October 29, 2022, the activity in AOCL was as follows: Thirteen Weeks Ended October 29, 2022 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at July 30, 2022 $ (136,006) $ 5,966 $ (130,040) Other comprehensive (loss) income before reclassifications (11,021) 2,723 (8,298) Reclassified gain from AOCL (1) — (3,909) (3,909) Tax effect — (20) (20) Other comprehensive loss after reclassifications (11,021) (1,206) (12,227) Ending balance at October 29, 2022 $ (147,027) $ 4,760 $ (142,267) Thirty-Nine Weeks Ended October 29, 2022 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at January 29, 2022 $ (120,689) $ 5,983 $ (114,706) Other comprehensive (loss) income before reclassifications (26,338) 10,447 (15,891) Reclassified gain from AOCL (1) — (11,718) (11,718) Tax effect — 48 48 Other comprehensive loss after reclassifications (26,338) (1,223) (27,561) Ending balance at October 29, 2022 $ (147,027) $ 4,760 $ (142,267) (1) Amount represents gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income. For the thirteen and thirty-nine weeks ended October 30, 2021, the activity in AOCL was as follows: Thirteen Weeks Ended October 30, 2021 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at July 31, 2021 $ (101,032) $ 767 $ (100,265) Other comprehensive (loss) income before reclassifications (5,629) 4,589 (1,040) Reclassified gain from AOCL (1) — (141) (141) Tax effect — (32) (32) Other comprehensive (loss) income after reclassifications (5,629) 4,416 (1,213) Ending balance at October 30, 2021 $ (106,661) $ 5,183 $ (101,478) Thirty-Nine Weeks Ended October 30, 2021 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at January 30, 2021 $ (97,772) $ (4,535) $ (102,307) Other comprehensive (loss) income before reclassifications (8,889) 6,818 (2,071) Reclassified loss from AOCL (1) — 3,010 3,010 Tax effect — (110) (110) Other comprehensive (loss) income after reclassifications (8,889) 9,718 829 Ending balance at October 30, 2021 $ (106,661) $ 5,183 $ (101,478) (1) Amount represents loss reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income.

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
	Oct. 29, 2022
Segment Reporting [Abstract]
Revenue from External Customers by Operating Segment [Table Text Block]	The Company’s net sales by operating segment for the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021 were as follows: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Hollister $ 457,752 $ 522,311 $ 1,323,492 $ 1,479,202 Abercrombie 422,332 382,849 1,174,445 1,072,213 Total $ 880,084 $ 905,160 $ 2,497,937 $ 2,551,415
Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country	The Company’s net sales by geographic area for the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021 were as follows: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 U.S. $ 674,555 $ 654,858 $ 1,837,760 $ 1,810,471 EMEA (1) 139,826 179,156 470,575 528,998 APAC (2) 28,293 38,215 85,968 125,489 Other (3) 37,410 32,931 103,634 86,457 International $ 205,529 $ 250,302 $ 660,177 $ 740,944 Total $ 880,084 $ 905,160 $ 2,497,937 $ 2,551,415 (1) Europe, Middle East and Africa (“EMEA”). (2) Asia-Pacific Region (“APAC”). (3) Other includes all sales that do not fall within the United States, EMEA, or APAC regions, which are derived primarily in Canada.

Summary of Significant Accoun_4

Summary of Significant Accounting Policies Condensed Consolidated Statements of Cash Flows reconciliation (Details) - USD ($) $ in Thousands	Oct. 29, 2022	Jan. 29, 2022	Oct. 30, 2021	Jan. 30, 2021
Condensed Statements of Cash Flows reconciliation [Abstract]
Cash and equivalents	$ 257,332	$ 823,139	$ 865,622	$ 1,104,862
Restricted Cash and Cash Equivalents	9,674	11,229	11,401	14,814
Restricted Cash and Cash Equivalents, Current	0	0	3,280	4,481
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 267,006	$ 834,368	$ 880,303	$ 1,124,157

Summary of Significant Accoun_5

Summary of Significant Accounting Policies Recent Accounting Pronouncements (Details)	9 Months Ended
	Oct. 29, 2022
Recent Accounting Pronouncements [Abstract]
Maximum Length Of Time Inventory Sales Hedged	12 months

Revenue Recognition (Details)

Revenue Recognition (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021	Jan. 29, 2022
Revenue Recognition [Abstract]
Revenue recognized from Gift Card Program	$ 21,194	$ 17,801	$ 66,847	$ 51,310
Revenue recognized from Customer Loyalty Program Liability	11,767	12,075	32,578	31,525
Gift Card Liability, Current	35,016	30,815	35,016	30,815	$ 36,984
Customer Loyalty Program Liability, Current	$ 22,930	$ 21,964	$ 22,930	$ 21,964	$ 22,757

Net Income (Loss) Per Share (De

Net Income (Loss) Per Share (Details) - shares shares in Thousands		3 Months Ended		9 Months Ended
		Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Weighted Average Shares Outstanding And Anti Dilutive Shares [Abstract]
Shares of Common Stock issued		103,300	103,300	103,300	103,300
Weighted-average treasury shares		(53,814)	(44,504)	(52,627)	(42,421)
Weighted-average — basic shares		49,486	58,796	50,673	60,879
Dilutive effect of share-based compensation awards		0	2,669	0	2,891
Weighted-average — diluted shares		49,486	61,465	50,673	63,770
Anti-dilutive shares (1)	[1]	4,199	1,228	4,285	1,212
[1]Reflects the total number of shares related to outstanding share-based compensation awards that have been excluded from the computation of net (loss) income per diluted share because the impact would have been anti-dilutive. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can achieve up to 200% of their target vesting amount and are reflected at the maximum vesting amount less any dilutive portion.

Fair Value (Assets and Liabilit

Fair Value (Assets and Liabilities at Fair Value) (Details) - USD ($) $ in Thousands		Oct. 29, 2022	Jan. 29, 2022
Fair Value, Recurring [Member]
Assets, Fair Value Disclosure [Abstract]
Cash and Cash Equivalents, Fair Value Disclosure	[1]	$ 51,722	$ 60,952
Derivative instruments (2)	[2]	3,802	4,973
Restricted Investments, Noncurrent	[3]	51,348	62,273
Restricted Cash Equivalents, Noncurrent	[1]	6,694	7,717
Total assets		113,566	135,915
Liabilities, Fair Value Disclosure [Abstract]
Derivative Liability		10
Total liabilities		10
Level 1 | Fair Value, Recurring [Member]
Assets, Fair Value Disclosure [Abstract]
Cash and Cash Equivalents, Fair Value Disclosure	[1]	51,722	49,309
Derivative instruments (2)	[2]	0	0
Restricted Investments, Noncurrent	[3]	1	1
Restricted Cash Equivalents, Noncurrent	[1]	1,544	5,391
Total assets		53,267	54,701
Liabilities, Fair Value Disclosure [Abstract]
Derivative Liability		0
Total liabilities		0
Level 2 | Fair Value, Recurring [Member]
Assets, Fair Value Disclosure [Abstract]
Cash and Cash Equivalents, Fair Value Disclosure	[1]	0	11,643
Derivative instruments (2)		3,802	4,973	[2]
Restricted Investments, Noncurrent	[3]	51,347	62,272
Restricted Cash Equivalents, Noncurrent	[1]	5,150	2,326
Total assets		60,299	81,214
Liabilities, Fair Value Disclosure [Abstract]
Derivative Liability		10	0
Total liabilities		10
Level 3 | Fair Value, Recurring [Member]
Assets, Fair Value Disclosure [Abstract]
Cash and Cash Equivalents, Fair Value Disclosure	[1]	0	0
Derivative instruments (2)	[2]	0	0
Restricted Investments, Noncurrent	[3]	0	0
Restricted Cash Equivalents, Noncurrent	[1]	0	0
Total assets		0	0
Liabilities, Fair Value Disclosure [Abstract]
Derivative Liability		0
Total liabilities		0
Senior Notes [Member]
Liabilities, Fair Value Disclosure [Abstract]
Gross borrowings outstanding, carrying amount		299,730	307,730
Gross borrowings outstanding, fair value		$ 283,245	$ 327,732
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate		875%
[1]Level 1 assets consisted of investments in money market funds and U.S. treasury bills. Level 2 assets consisted of time deposits.[2] (2) Level 2 assets consisted primarily of foreign currency exchange forward contracts.

Property and Equipment, Net (De

Property and Equipment, Net (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Oct. 29, 2022		Oct. 30, 2021	Oct. 29, 2022		Oct. 30, 2021	Jan. 29, 2022
Property, Plant and Equipment [Line Items]
Property and equipment, at cost	$ 2,502,008			$ 2,502,008			$ 2,453,493
Less: Accumulated depreciation and amortization	(1,959,870)			(1,959,870)			(1,945,157)
Property and equipment, net	542,138			542,138			$ 508,336
Property and equipment asset impairment (1)	2,539	[1]	$ 1,237	4,643	[1]	$ 1,983
Asset Impairment Charges	$ 3,744		$ 6,749	$ 9,336		$ 10,199
[1] (1) Amounts include $0.6 million of store asset impairment and $1.9 million other asset impairment for the thirteen weeks ended October 29, 2022 and $2.7 million of store asset impairment and $1.9 million other asset impairment for the thirty-nine weeks ended October 29, 2022. Amounts for the thirteen and thirty-nine weeks ended October 30, 2021 only include store asset impairment.

Leases (Details)

Leases (Details) - USD ($) $ in Thousands		3 Months Ended				9 Months Ended
		Oct. 29, 2022		Oct. 30, 2021		Oct. 29, 2022		Oct. 30, 2021
Leases [Abstract]
Single lease cost	[1]	$ 63,263		$ 66,969		$ 182,796		$ 207,046
Variable lease cost		40,681	[2]	26,409	[2]	106,359	[2]	68,875
Operating lease right-of-use asset impairment	[3]	1,205		5,512		4,693		8,216
Sublease Income		(908)	[4]	(1,068)	[4]	(2,869)		(3,256)
Operating lease cost		104,241		97,822		290,979		280,881
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability						196,003		26,473
Cash paid for operating lease liabilities						210,394		312,854
LesseeOperatingLeaseLeasesNotYetCommencedLiability		31,500				31,500
Rent Abatement Benefit to Variable Lease Cost		$ 800		$ 1,700		$ 3,300		$ 14,600
[1]Included amortization and interest expense associated with operating lease right-of-use assets and the impact from remeasurement of operating lease liabilities.[2]Includes variable payments related to both lease and nonlease components, such as contingent rent payments made by the Company based on performance, and payments related to taxes, insurance, and maintenance costs, as well as the benefit of $0.8 million and $3.3 million of rent abatements during the thirteen and thirty-nine weeks ended October 29, 2022, respectively, related to the effects of the COVID-19 pandemic that resulted in the total payments required by the modified contract being substantially the same as or less than total payments required by the original contract. The benefit related to rent abatements recognized during the thirteen and thirty-nine weeks ended October 30, 2021 was $1.7 million and $14.6 million respectively.[3] Refer to Note 8, “ ASSET IMPAIRMENT ,” for details related to operating lease right-of-use asset impairment charges. (4) The terms of the sublease agreement entered into by the Company with a third party during Fiscal 2020 related to one of its previous flagship store locations have not changed materially from that disclosed in Note 8, “LEASES,” of the Notes to Consolidated Financial Statements contained in “Item 8. Financial Statements and Supplementary Data” of the Fiscal 2021 Form 10-K. Sublease income is recognized in other operating income, net on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income.

Asset Impairment (Details)

Asset Impairment (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Oct. 29, 2022		Oct. 30, 2021	Oct. 29, 2022		Oct. 30, 2021	Jan. 29, 2022
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Property and equipment asset impairment (1)	$ 2,539	[1]	$ 1,237	$ 4,643	[1]	$ 1,983
Asset Impairment Charges	3,744		6,749	9,336		10,199
Operating Lease, Right-of-Use Asset	713,166			713,166			$ 698,231
Retail Site
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Property and equipment asset impairment (1)	600			2,700
Operating Lease, Impairment Loss	1,205		5,512	4,693		8,216
Other Capitalized Property Plant and Equipment
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Property and equipment asset impairment (1)	1,900			1,900
Fair Value, Recurring [Member]
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Store Assets, including property and equipment and operating lease right-of-use assets	38,700		19,500	38,700		19,500
Operating Lease, Right-of-Use Asset	$ 37,800		$ 17,000	$ 37,800		$ 17,000
[1] (1) Amounts include $0.6 million of store asset impairment and $1.9 million other asset impairment for the thirteen weeks ended October 29, 2022 and $2.7 million of store asset impairment and $1.9 million other asset impairment for the thirty-nine weeks ended October 29, 2022. Amounts for the thirteen and thirty-nine weeks ended October 30, 2021 only include store asset impairment.

Rabbi Trust Assets (Details)

Rabbi Trust Assets (Details) - Fair Value, Recurring [Member] - USD ($) $ in Thousands		Oct. 29, 2022	Jan. 29, 2022
Defined Benefit Plan, Plan Assets, Category [Line Items]
Restricted Investments, Noncurrent	[1]	$ 51,348	$ 62,273
Level 2
Defined Benefit Plan, Plan Assets, Category [Line Items]
Restricted Investments, Noncurrent	[1]	51,347	62,272
Level 1
Defined Benefit Plan, Plan Assets, Category [Line Items]
Restricted Investments, Noncurrent	[1]	$ 1	$ 1
[1]Level 1 assets consisted of investments in money market funds. Level 2 assets consisted of trust-owned life insurance policies.

Income Taxes (Details)

Income Taxes (Details) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Valuation Allowance [Line Items]
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ (200,000)	$ (3,500,000)	$ (13,600,000)
Valuation Allowance, Deferred Tax Asset, Discrete Benefit, Increase (Decrease) Amount			23,400,000
Pre-Tax Losses Without Tax Benefits Recognized	30,000,000		69,700,000
Valuation Allowance, Deferred Tax Asset, Increase (Decrease) Amount	5,600,000		12,800,000
Pre-Tax Losses Without Tax Benefits Recognized	30,000,000		69,700,000
Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability			3,900,000
Income Tax Expense (Benefit)	10,966,000	$ 16,383,000	14,413,000	$ 15,560,000
CHINA
Valuation Allowance [Line Items]
Deferred Tax Assets, Other	$ 11,200,000		$ 11,200,000

Borrowings (Details)

Borrowings (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Oct. 29, 2022	Oct. 29, 2022	Oct. 30, 2021	Jan. 29, 2022
Long-Term Borrowings [Line Items]
Debt Instrument, Repurchased Face Amount	$ 8,000	$ 8,000
(Gain) loss on extinguishment of debt	100	52	$ (5,347)
Line of Credit Facility, Remaining Borrowing Capacity	399,400	399,400
Long-term Debt, Excluding Current Maturities	296,532	296,532		$ 303,574
Schedule of Future Payments of the Term Loan Facility
ABL Facility, covenant terms, minimum remaining borrowing capacity	359,400	359,400
Letters of Credit Outstanding, Amount	$ (600)	$ (600)
Senior Notes [Member]
Long-Term Borrowings [Line Items]
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	875%	875%
Gross borrowings outstanding, carrying amount	$ 299,730	$ 299,730		307,730
Unamortized discount	(3,198)	(3,198)
Term Loan Facility
Long-Term Borrowings [Line Items]
Unamortized Debt Issuance Expense Fees Paid to Lenders				(4,156)
Long-term Debt				$ 303,574
ABL Facility
Long-Term Borrowings [Line Items]
Maximum borrowing capacity	$ 400,000	$ 400,000

Borrowings Schedule of Short-te

Borrowings Schedule of Short-term borrowings (Details) $ in Millions	Oct. 29, 2022 USD ($)
Short-term debt disclosure [Abstract]
Line of Credit Facility, Remaining Borrowing Capacity	$ 399.4

Share-Based Compensation (Detai

Share-Based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	$ (426)	$ (984)	$ (14,432)	$ (13,044)
Payment, Tax Withholding, Share-based Payment Arrangement	426	984	14,432	13,044
Share-based compensation expense	7,310	7,332	23,426	22,269
Tax benefit recognized related to share-based compensation expense	635	806	2,615	2,492
Share-based Payment Arrangement, Exercise of Option, Tax Benefit	(29)	150	1,970	4,166
Total grant date fair value of awards vested			1,757
Share-based Payment Arrangement, Cancellation of Option, Tax Charge	(10)	0	(213)	(3)
Share-based Payment Arrangement, Discrete Income Tax Benefit (Charge)	(39)	150	1,757	4,163
Service-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost, net of estimated forfeitures	39,040		$ 39,040
Unrecognized compensation cost, weighted-average period of recognition			1 year 3 months 18 days
Total grant date fair value of awards granted			$ 28,246	23,760
Total grant date fair value of awards vested			16,702	13,232
Performance-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost, net of estimated forfeitures	0		$ 0
Unrecognized compensation cost, weighted-average period of recognition			0 years
Total grant date fair value of awards granted			$ 5,600	5,059
Total grant date fair value of awards vested			4,482	0
Market-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost, net of estimated forfeitures	15,602		$ 15,602
Unrecognized compensation cost, weighted-average period of recognition			10 months 24 days
Total grant date fair value of awards granted			$ 3,852	4,492
Total grant date fair value of awards vested			4,105	3,390
Additional Paid-in Capital [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	(1,396)	(918)	(25,575)	(17,247)
Share-based compensation expense	$ 7,310	$ 7,332	$ 23,426	$ 22,269

Share-Based Compensation (Restr

Share-Based Compensation (Restricted Stock Units Activity) (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Exercise of Option, Tax Benefit		$ (29)	$ 150	$ 1,970	$ 4,166
Restricted Stock Unit Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 30, 2021				236,139
Number of Underlying Shares, Forfeited				(37,800)
Number of Underlying Shares, Ending Balance at July 31, 2021		198,339		198,339
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Beginning Balance at January 30, 2021				$ 32.55
Weighted-Average Grant Date Fair Value, Forfeited				48.72
Weighted-Average Grant Date Fair Value, Ending Balance at July 31, 2021		$ 29.47		$ 29.47
Service-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount		$ 39,040		$ 39,040
Restricted Stock Unit Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 30, 2021				2,532,240
Number of Underlying Shares, Granted				983,139
Number of Underlying Shares, Adjustments for performance achievement				0
Number of Underlying Shares, Vested				(927,346)
Number of Underlying Shares, Forfeited				(136,982)
Number of Underlying Shares, Ending Balance at July 31, 2021		2,451,051		2,451,051
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Beginning Balance at January 30, 2021				$ 17.16
Weighted-Average Grant Date Fair Value, Granted				28.73
Weighted-Average Grant Date Fair Value, Adjustments for performance achievement				0
Weighted-Average Grant Date Fair Value, Vested				18.01
Weighted-Average Grant Date Fair Value, Forfeited				20.37
Weighted-Average Grant Date Fair Value, Ending Balance at July 31, 2021		$ 21.30		$ 21.30
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition				1 year 3 months 18 days
Performance-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount		$ 0		$ 0
Restricted Stock Unit Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 30, 2021				340,149
Number of Underlying Shares, Granted				185,197
Number of Underlying Shares, Adjustments for performance achievement				5,668
Number of Underlying Shares, Vested				(194,465)
Number of Underlying Shares, Forfeited				0
Number of Underlying Shares, Ending Balance at July 31, 2021	[1]	336,549		336,549
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Beginning Balance at January 30, 2021				$ 27.08
Weighted-Average Grant Date Fair Value, Granted				30.24
Weighted-Average Grant Date Fair Value, Adjustments for performance achievement				23.05
Weighted-Average Grant Date Fair Value, Vested				23.05
Weighted-Average Grant Date Fair Value, Forfeited				0
Weighted-Average Grant Date Fair Value, Ending Balance at July 31, 2021		$ 31.08		$ 31.08
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition				0 years
Market-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount		$ 15,602		$ 15,602
Restricted Stock Unit Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 30, 2021				680,184
Number of Underlying Shares, Granted				92,603
Number of Underlying Shares, Adjustments for performance achievement				18,881
Number of Underlying Shares, Vested				(113,284)
Number of Underlying Shares, Forfeited				(16,247)
Number of Underlying Shares, Ending Balance at July 31, 2021	[1]	662,137		662,137
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Beginning Balance at January 30, 2021				$ 22.81
Weighted-Average Grant Date Fair Value, Granted				41.60	$ 56.99
Weighted-Average Grant Date Fair Value, Adjustments for performance achievement				36.24
Weighted-Average Grant Date Fair Value, Vested				36.24
Weighted-Average Grant Date Fair Value, Forfeited				16.24
Weighted-Average Grant Date Fair Value, Ending Balance at July 31, 2021		$ 23.68		$ 23.68
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition				10 months 24 days
[1]Unvested shares related to restricted stock units with performance-based and market-based vesting conditions are reflected at 100% of their target vesting amount in the table above. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can be achieved at up to 200% of their target vesting amount.

Share-Based Compensation (Res_2

Share-Based Compensation (Restricted Stock Units Assumptions) (Details) - $ / shares	9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Document Period End Date	Oct. 29, 2022
City Area Code	(614)
Market-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant date market price (in dollars per share)	$ 30.24	$ 36.15
Fair value (in dollars per share)	$ 41.60	$ 56.99
Price volatility	66%	65%
Expected term (years)	2 years 9 months 18 days	2 years 6 months
Risk-free interest rate	2.50%	0.30%
Dividend yield	0%	0%
Average volatility of peer companies	72.30%	76%
Average correlation coefficient of peer companies	0.5150	0.5130

Share-Based Compensation (Stock

Share-Based Compensation (Stock Appreciation Rights Activity) (Details)	9 Months Ended
	Oct. 29, 2022 USD ($) $ / shares shares
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | $	$ 1,757,000
Stock Appreciation Rights Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 30, 2021 | shares	236,139
Number of Underlying Shares, Forfeited | shares	(37,800)
Number of Underlying Shares, Ending Balance at July 31, 2021 | shares	198,339
Number of Underlying shares, Stock appreciation rights exercisable | shares	198,339
Stock Appreciation Rights, Weighted-Average Exercise Price
Weighted-Average Grant Date Fair Value, Beginning Balance at January 30, 2021 | $ / shares	$ 32.55
Weighted-Average Exercise Price, Forfeited or expired | $ / shares	48.72
Weighted-Average Grant Date Fair Value, Ending Balance at July 31, 2021 | $ / shares	29.47
Weighted-Average Exercise Price, Stock appreciation rights exercisable | $ / shares	$ 29.47
Aggregate Intrinsic Value, Outstanding | $	$ 0
Aggregate Intrinsic Value, Stock appreciation rights exercisable | $	$ 0
Weighted-Average Remaining Contractual Life, Outstanding	1 year 10 months 24 days
Weighted-Average Remaining Contractual Life, Stock appreciation rights exercisable	1 year 10 months 24 days

Derivative Instruments (Outstan

Derivative Instruments (Outstanding Foreign Exchange Forward Contracts) (Details) $ in Thousands	Oct. 29, 2022 USD ($)	[1]
Euro Member Countries, Euro
Derivative [Line Items]
Notional Amount	$ 50,728
United Kingdom, Pounds
Derivative [Line Items]
Notional Amount	58,382
Canada, Dollars
Derivative [Line Items]
Notional Amount	2,232
Japan, Yen
Derivative [Line Items]
Notional Amount	$ 2,254
[1]Amounts reported are the U.S. Dollar notional amounts outstanding as of October 29, 2022.

Derivative Instruments (Derivat

Derivative Instruments (Derivative Fair Values on the Condensed Consolidated Balance Sheets) (Details) - USD ($) $ in Thousands		Oct. 29, 2022	Jan. 29, 2022
Fair Value, Recurring [Member]
The location and amounts of derivative fair values on the Condensed Consolidated Balance Sheets
Other current assets	[1]	$ 3,802	$ 4,973
Accrued expenses		10
Designated As Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Foreign Currency Cash Flow Hedge Asset at Fair Value		3,802	4,973
Foreign Currency Cash Flow Hedge Liability at Fair Value		10	0
Not Designated as Hedging Instruments
Derivative Instruments, Gain (Loss) [Line Items]
Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value		0	0
Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Liability at Fair Value		0	0
Level 2 | Fair Value, Recurring [Member]
The location and amounts of derivative fair values on the Condensed Consolidated Balance Sheets
Other current assets		3,802	4,973	[1]
Accrued expenses		$ 10	$ 0
[1] (2) Level 2 assets consisted primarily of foreign currency exchange forward contracts.

Derivative Instruments (Deriv_2

Derivative Instruments (Derivative Gains (Losses) on the Condensed Consolidated Statement of Operations) (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Reclassified from AOCL into Earnings (Effective Portion)	[1]	$ 3,909	$ 141	$ 11,718	$ (3,010)
Gain/(Loss)		504	487	2,276	324
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax	[2]	$ 2,723	$ 4,589	$ 10,447	$ 6,818
[1]Amount represents gain (loss) reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) when the hedged item affects earnings, which is when merchandise is converted to cost of sales, exclusive of depreciation and amortization.[2]Amount represents the change in fair value of derivative instruments.

Derivative Instruments (Details

Derivative Instruments (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021	Jan. 29, 2022
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated AOCL into Income, Effective Portion, Net	[1]	$ 3,909	$ 141	$ 11,718	$ (3,010)
Length of time inventory sales hedged (in months)				12 months
Euro Member Countries, Euro
Derivative Instruments, Gain (Loss) [Line Items]
Notional Amount	[2]	50,728		$ 50,728
United Kingdom, Pounds
Derivative Instruments, Gain (Loss) [Line Items]
Notional Amount	[2]	58,382		58,382
Canada, Dollars
Derivative Instruments, Gain (Loss) [Line Items]
Notional Amount	[2]	2,232		2,232
Japan, Yen
Derivative Instruments, Gain (Loss) [Line Items]
Notional Amount	[2]	2,254		2,254
Fair Value, Recurring [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other current assets	[3]	3,802		3,802		$ 4,973
Accrued expenses		10		10
Level 2 | Fair Value, Recurring [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other current assets		3,802		3,802		4,973	[3]
Accrued expenses		$ 10		$ 10		$ 0
[1]Amount represents gain (loss) reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) when the hedged item affects earnings, which is when merchandise is converted to cost of sales, exclusive of depreciation and amortization.[2]Amounts reported are the U.S. Dollar notional amounts outstanding as of October 29, 2022.[3] (2) Level 2 assets consisted primarily of foreign currency exchange forward contracts.

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended				9 Months Ended
	Oct. 29, 2022		Oct. 30, 2021		Oct. 29, 2022		Oct. 30, 2021
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	$ (130,040)		$ (100,265)		$ (114,706)		$ (102,307)
Other comprehensive (loss) income before reclassifications	(8,298)		(1,040)		(15,891)		(2,071)
Reclassified gain (loss) from AOCL	(3,909)	[1]	(141)	[2]	(11,718)	[1]	3,010	[2]
Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent	(20)		(32)		48		(110)
Other comprehensive (loss) income	(12,227)		(1,213)	[3]	(27,561)		829
Ending balance at October 29, 2022	(142,267)		(101,478)		(142,267)		(101,478)
Foreign Currency Translation Adjustment
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	(136,006)		(101,032)		(120,689)		(97,772)
Other comprehensive (loss) income before reclassifications	(11,021)		(5,629)		(26,338)		(8,889)
Reclassified gain (loss) from AOCL	0		0		0		0
Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent	0		0		0		0
Other comprehensive (loss) income	(11,021)		(5,629)	[3]	(26,338)		(8,889)
Ending balance at October 29, 2022	(147,027)		(106,661)		(147,027)		(106,661)
Unrealized Gain (Loss) on Derivative Financial Instruments
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	5,966		767		5,983		(4,535)
Other comprehensive (loss) income before reclassifications	2,723		4,589		10,447		6,818
Reclassified gain (loss) from AOCL	(3,909)	[1]	(141)	[2]	(11,718)	[1]	3,010	[2]
Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent	(20)		(32)		48		(110)
Other comprehensive (loss) income	(1,206)		4,416	[3]	(1,223)		9,718
Ending balance at October 29, 2022	$ 4,760		$ 5,183		$ 4,760		$ 5,183
[1]Amount represents gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income.[2]Amount represents loss reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income.[3]Amount represents loss reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income.

Segment Reporting (Segment Repo

Segment Reporting (Segment Reporting Information, by Segment) (Details)	3 Months Ended	9 Months Ended
	Oct. 29, 2022	Oct. 29, 2022
Segment Reporting Information [Line Items]
Number of Operating Segments	2
Number of reportable segments		1

Segment Reporting (Net Sales by

Segment Reporting (Net Sales by Brand) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Schedule of Revenue by Brand [Line Items]
Net sales	$ 880,084	$ 905,160	$ 2,497,937	$ 2,551,415
Hollister
Schedule of Revenue by Brand [Line Items]
Net sales	457,752	522,311	1,323,492	1,479,202
Abercrombie
Schedule of Revenue by Brand [Line Items]
Net sales	$ 422,332	$ 382,849	$ 1,174,445	$ 1,072,213

Segment Reporting (Sales by Geo

Segment Reporting (Sales by Geographic Area) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Net sales	$ 880,084	$ 905,160	$ 2,497,937	$ 2,551,415
United States
Net sales	674,555	654,858	1,837,760	1,810,471
EMEA [Member]
Net sales	139,826	179,156	470,575	528,998
Asia Pacific [Member]
Net sales	28,293	38,215	85,968	125,489
Other
Net sales	37,410	32,931	103,634	86,457
International [Member]
Net sales	$ 205,529	$ 250,302	$ 660,177	$ 740,944